If you made any changes in Pure, your changes will be visible here soon.

Research Output 1959 2019

Filter
Article
2019
1 Citation (Scopus)

High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure

Aimo, A., Januzzi, J. L., Vergaro, G., Ripoli, A., Latini, R., Masson, S., Magnoli, M., Anand, I., Cohn, J. N., Tavazzi, L., Tognoni, G., Gravning, J., Ueland, T., Nymo, S. H., Rocca, H. P. B. L., Bayes-Genis, A., Lupón, J., de Boer, R. A., Yoshihisa, A., Takeishi, Y. & 10 others, Egstrup, M., Gustafsson, I., Gaggin, H. K., Eggers, K. M., Huber, K., Tentzeris, I., Wilson Tang, W. H., Grodin, J. L., Passino, C. & Emdin, M., Feb 15 2019, In : International Journal of Cardiology. 277, p. 166-172 7 p.

Research output: Contribution to journalArticle

Troponin T
Brain Natriuretic Peptide
Glomerular Filtration Rate
Heart Failure
C-Reactive Protein
2018
2 Citations (Scopus)

Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial

Chang, K. W., Beri, N., Nguyen, N. H., Arbit, B., Fox, S., Mojaver, S., Clopton, P., Tam, S. W., Taylor, A. L., Cohn, J. N., Maisel, A. S. & Anand, I., May 1 2018, In : Journal of cardiac failure. 24, 5, p. 303-309 7 p.

Research output: Contribution to journalArticle

African Americans
Heart Failure
Hospitalization
Confidence Intervals
Mortality
8 Citations (Scopus)

sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T

Emdin, M., Aimo, A., Vergaro, G., Bayes-Genis, A., Lupón, J., Latini, R., Meessen, J., Anand, I., Cohn, J. N., Gravning, J., Gullestad, L., Broch, K., Ueland, T., Nymo, S. H., Brunner-La Rocca, H. P., de Boer, R. A., Gaggin, H. K., Ripoli, A., Passino, C. & Januzzi, J. L., Nov 6 2018, In : Journal of the American College of Cardiology. 72, 19, p. 2309-2320 12 p.

Research output: Contribution to journalArticle

Troponin T
Carcinogenesis
Heart Failure
Natriuretic Peptides
Cause of Death
16 Citations (Scopus)

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes

Cosmi, F., Shen, L., Magnoli, M., Abraham, W. T., Anand, I. S., Cleland, J. G., Cohn, J. N., Cosmi, D., De Berardis, G., Dickstein, K., Franzosi, M. G., Gullestad, L., Jhund, P. S., Kjekshus, J., Køber, L., Lepore, V., Lucisano, G., Maggioni, A. P., Masson, S., McMurray, J. J. V. & 9 others, Nicolucci, A., Petrarolo, V., Robusto, F., Staszewsky, L., Tavazzi, L., Teli, R., Tognoni, G., Wikstrand, J. & Latini, R., May 1 2018, In : European Journal of Heart Failure. 20, 5, p. 888-895 8 p.

Research output: Contribution to journalArticle

Heart Failure
Insulin
Propensity Score
Hospitalization
Therapeutics
2017
1 Citation (Scopus)

BMJ open protocol for the HAPPY Hearts study: Cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: A prospective, observational cohort study

Boreskie, K. F., Kehler, D. S., Costa, E. C., Cortez, P. C., Berkowitz, I., Hamm, N. C., Moffatt, T. L., Stammers, A. N., Kimber, D. E., Hiebert, B. M., Kent, D. E., Cornish, D. E., Blewett, H., Nguyen, T., Arora, R. C., Strachan, S. M., Semenchuk, B. N., Hay, J. L., Cohn, J. N. & Duhamel, T. A., Jan 1 2017, In : BMJ open. 7, 11, e018249.

Research output: Contribution to journalArticle

Open Access
Observational Studies
Cohort Studies
Myocardial Infarction
Manitoba
Blood Pressure
3 Citations (Scopus)
Nebivolol
Atenolol
Placebos
Blood Pressure
Arteries
1 Citation (Scopus)

Office Blood Pressure and Cardiovascular Disease: Pathophysiologic Implications for Diagnosis and Treatment

Cohn, J. N., Duprez, D., Hoke, L., Florea, N. & Duval, S., May 1 2017, In : Hypertension. 69, 5, p. e14-e20

Research output: Contribution to journalArticle

Hematologic Diseases
Cardiovascular Diseases
Blood Pressure
14 Citations (Scopus)

Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial

Dauriz, M., Targher, G., Temporelli, P. L., Lucci, D., Gonzini, L., Nicolosi, G. L., Marchioli, R., Tognoni, G., Latini, R., Cosmi, F., Tavazzi, L., Maggioni, A. P., Moccetti, T., Rossi, M. G., Pasotti, E., Vaghi, F., Roncarolo, P., Zunino, M. T., Matta, F., Actis Perinetto, E. & 31 others, Gaita, F., Azzaro, G., Zanetta, M., Paino, A. M., Parravicini, U., Vegis, D., Conte, R., Ferraro, P., De Bernardi, A., Morelloni, S., Fagnani, M., Greco Lucchina, P., Montagna, L., Bellone, E., Sappè, D., Ferraro, F., Delucchi, M., Reynaud, S. G., Dore, M., La Brocca, A., Massobrio, N., Bo, L., Trinchero, R., Imazio, M., Brocchi, G., Nejrotti, A., Rissone, L., Gabasio, S., Zocchi, C., Cohn, J. N. & on behalf of the GISSI-HF Investigators, Jul 1 2017, In : Journal of the American Heart Association. 6, 7, e005156.

Research output: Contribution to journalArticle

Open Access
Prediabetic State
Diabetes Mellitus
Heart Failure
Cause of Death
Survival
2016
25 Citations (Scopus)

Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival

Florea, V., Rector, T. S., Anand, I. & Cohn, J. N., Jul 1 2016, In : Circulation: Heart Failure. 9, 7

Research output: Contribution to journalArticle

Heart Failure
Survival
Valsartan
Biomarkers
Hemodynamics
2015
29 Citations (Scopus)

Calculated plasma volume status and prognosis in chronic heart failure

Ling, H. Z., Flint, J., Damgaard, M., Bonfils, P. K., Cheng, A. S., Aggarwal, S., Velmurugan, S., Mendonca, M., Rashid, M., Kang, S., Papalia, F., Weissert, S., Coats, C. J., Thomas, M., Kuskowski, M. A., Cohn, J. N., Woldman, S., Anand, I. & Okonko, D. O., Jan 1 2015, In : European Journal of Heart Failure. 17, 1, p. 35-43 9 p.

Research output: Contribution to journalArticle

Plasma Volume
Heart Failure
Valsartan
Brain Natriuretic Peptide
Hematocrit
50 Citations (Scopus)

Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: Insights from the GISSI-HF and Val-HeFT trials

Rossignol, P., Masson, S., Barlera, S., Girerd, N., Castelnovo, A., Zannad, F., Clemenza, F., Tognoni, G., Anand, I., Cohn, J. N., Anker, S. D., Tavazzi, L. & Latini, R., Apr 1 2015, In : European Journal of Heart Failure. 17, 4, p. 424-433 10 p.

Research output: Contribution to journalArticle

Heart Failure
Body Weight
Mortality
Plasma Volume
C-Reactive Protein
10 Citations (Scopus)

Regular Wine Consumption in Chronic Heart Failure: Impact on Outcomes, Quality of Life, and Circulating Biomarkers

GISSI-HF Investigators, May 4 2015, In : Circulation: Heart Failure. 8, 3, p. 428-437 10 p.

Research output: Contribution to journalArticle

Open Access
Wine
Heart Failure
Biomarkers
Quality of Life
Depression
2014
11 Citations (Scopus)

Effect of Fixed-Dose Combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure

Anand, I., Win, S., Rector, T. S., Cohn, J. N. & Taylor, A. L., Sep 1 2014, In : Circulation: Heart Failure. 7, 5, p. 759-765 7 p.

Research output: Contribution to journalArticle

Hospitalization
Heart Failure
Placebos
isosorbide-hydralazine combination
Mortality
22 Citations (Scopus)

G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: Results of A-HeFT

McNamara, D. M., Taylor, A. L., Tam, S. W., Worcel, M., Yancy, C. W., Hanley-Yanez, K., Cohn, J. N. & Feldman, A. M., Jan 1 2014, In : JACC: Heart Failure. 2, 6, p. 551-557 7 p.

Research output: Contribution to journalArticle

Isosorbide Dinitrate
Hydralazine
Guanine Nucleotides
African Americans
Carrier Proteins
60 Citations (Scopus)

Prognostic value of soluble ST2 in the Valsartan heart failure trial

Anand, I., Rector, T. S., Kuskowski, M. A., Snider, J. & Cohn, J. N., Jan 1 2014, In : Circulation: Heart Failure. 7, 3, p. 418-426 9 p.

Research output: Contribution to journalArticle

Valsartan
Heart Failure
Natriuretic Peptides
Proportional Hazards Models
Hospitalization
2013
88 Citations (Scopus)

Baseline and serial measurements of galectin-3 in patients with heart failure: Relationship to prognosis and effect of treatment with valsartan in the Val-HeFT

Anand, I., Rector, T. S., Kuskowski, M. A., Adourian, A., Muntendam, P. & Cohn, J. N., May 1 2013, In : European Journal of Heart Failure. 15, 5, p. 511-518 8 p.

Research output: Contribution to journalArticle

Valsartan
Galectin 3
Heart Failure
Hospitalization
Therapeutics
10 Citations (Scopus)
Lisinopril
Blood Vessels
Blood Pressure
Health
Therapeutics
34 Citations (Scopus)

Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone systemblockade in patients with heart failure: Insights from the Val-HeFT study

Lesogor, A., Cohn, J. N., Latini, R., Tognoni, G., Krum, H., Massie, B., Zalewski, A., Kandra, A., Hua, T. A. & Gimpelewicz, C., Dec 16 2013, In : European Journal of Heart Failure. 15, 11, p. 1236-1244 9 p.

Research output: Contribution to journalArticle

Valsartan
Angiotensins
Aldosterone
Renin
Heart Failure
2012
13 Citations (Scopus)

Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the african-american heart failure trial

Taylor, A. L., Sabolinski, M. L., Tam, S. W., Ziesche, S., Ghali, J. K., Archambault, W. T., Worcel, M. & Cohn, J. N., Aug 1 2012, In : Journal of Cardiac Failure. 18, 8, p. 600-606 7 p.

Research output: Contribution to journalArticle

Isosorbide Dinitrate
Hydralazine
African Americans
Heart Failure
Disease-Free Survival
158 Citations (Scopus)

Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: Data from 2 large randomized clinical trials

Masson, S., Anand, I., Favero, C., Barlera, S., Vago, T., Bertocchi, F., Maggioni, A. P., Tavazzi, L., Tognoni, G., Cohn, J. N. & Latini, R., Jan 17 2012, In : Circulation. 125, 2, p. 280-288 9 p.

Research output: Contribution to journalArticle

Troponin T
Randomized Controlled Trials
Heart Failure
Valsartan
Brain Natriuretic Peptide
15 Citations (Scopus)

Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction

Miedema, M. D., Cohn, J. N., Garberich, R. F., Knickelbine, T., Graham, K. J. & Henry, T. D., Aug 1 2012, In : American Heart Journal. 164, 2, p. 259-267 9 p.

Research output: Contribution to journalArticle

Drug Therapy
Coronary Disease
Primary Prevention
ST Elevation Myocardial Infarction
Databases
2011
4 Citations (Scopus)

Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)

Mitchell, J. E., Tam, S. W., Trivedi, K., Taylor, A. L., O'Neal, W., Cohn, J. N. & Worcel, M., Jan 1 2011, In : American Heart Journal. 162, 1, p. 154-159 6 p.

Research output: Contribution to journalArticle

African Americans
Atrial Fibrillation
Heart Failure
Mortality
Blood Pressure
3 Citations (Scopus)

Inhibiting LV remodeling-the need for a targeted approach

Cohn, J. N., May 1 2011, In : Nature Reviews Cardiology. 8, 5, p. 248-249 2 p.

Research output: Contribution to journalArticle

Ventricular Remodeling
Angiotensin Receptor Antagonists
Renin-Angiotensin System
Angiotensin-Converting Enzyme Inhibitors
Renin
16 Citations (Scopus)

Vascular and cardiac functional and structural screening to identify risk of future morbid events: Preliminary observations

Duprez, D., Florea, N., Zhong, W., Grandits, G. A., Hawthorne, C. K., Hoke, L. & Cohn, J. N., Sep 1 2011, In : Journal of the American Society of Hypertension. 5, 5, p. 401-409 9 p.

Research output: Contribution to journalArticle

Blood Vessels
Cardiovascular Abnormalities
Asymptomatic Diseases
ROC Curve
LDL Cholesterol
2010
28 Citations (Scopus)

Digoxin use and heart failure outcomes: Results from the valsartan heart failure trial (Val-HeFT)

Butler, J., Anand, I., Kuskowski, M. A., Rector, T., Carson, P. & Cohn, J. N., Sep 1 2010, In : Congestive Heart Failure. 16, 5, p. 191-195 5 p.

Research output: Contribution to journalArticle

Valsartan
Digoxin
Heart Failure
Hospitalization
Confidence Intervals
48 Citations (Scopus)

Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: Data from the Valsartan heart failure trial (Val-HeFT)

Masson, S., Solomon, S., Angelici, L., Latini, R., Anand, I. S., Prescott, M., Maggioni, A. P., Tognoni, G. & Cohn, J. N., Dec 1 2010, In : Journal of cardiac failure. 16, 12, p. 964-970 7 p.

Research output: Contribution to journalArticle

Valsartan
Renin
Angiotensin-Converting Enzyme Inhibitors
Heart Failure
Therapeutics

President's page

Cohn, J. N., Dec 1 2010, In : Cardiovascular Drugs and Therapy. 24, 5-6, 1 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Role of the renin-angiotensin system in cardiovascular disease

Cohn, J. N., Aug 1 2010, In : Cardiovascular Drugs and Therapy. 24, 4, p. 341-344 4 p.

Research output: Contribution to journalArticle

Medication Therapy Management
Adrenergic beta-Antagonists
Angiotensin Receptors
Angiotensin Receptor Antagonists
Genetic Predisposition to Disease
149 Citations (Scopus)

Serial measurement of growth-differentiation factor-15 in heart failure: Relation to disease severity and prognosis in the valsartan heart failure trial

Anand, I., Kempf, T., Rector, T. S., Tapken, H., Allhoff, T., Jantzen, F., Kuskowski, M. A., Cohn, J. N., Drexler, H. & Wollert, K. C., Oct 5 2010, In : Circulation. 122, 14, p. 1387-1395 9 p.

Research output: Contribution to journalArticle

Valsartan
Growth Differentiation Factor 15
Heart Failure
Troponin T
Biomarkers
2009
26 Citations (Scopus)

Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia

Cohn, J. N., Wilson, D. J., Neutel, J., Houston, M., Weinberger, M. H., Grimm, R., Smith, D. H. G. & Sun, W., Feb 16 2009, In : American Journal of Hypertension. 22, 2, p. 137-144 8 p.

Research output: Contribution to journalArticle

Dyslipidemias
Compliance
Amlodipine
Placebos
Therapeutics
52 Citations (Scopus)

Endothelial Nitric Oxide Synthase (NOS3) Polymorphisms in African Americans With Heart Failure: Results From the A-HeFT Trial

McNamara, D. M., Tam, S. W., Sabolinski, M. L., Tobelmann, P., Janosko, K., Venkitachalam, L., Ofili, E., Yancy, C., Feldman, A. M., Ghali, J. K., Taylor, A. L., Cohn, J. N. & Worcel, M., Apr 1 2009, In : Journal of Cardiac Failure. 15, 3, p. 191-198 8 p.

Research output: Contribution to journalArticle

Nitric Oxide Synthase Type III
African Americans
Heart Failure
Genetic Heterogeneity
Genotype

ISCP President's page

Cohn, J. N., Jun 1 2009, In : Cardiovascular Drugs and Therapy. 23, 3, p. 255-256 2 p.

Research output: Contribution to journalArticle

President's page: Beijing 2009

Cohn, J. N., Oct 1 2009, In : Cardiovascular Drugs and Therapy. 23, 5, p. 419-423 5 p.

Research output: Contribution to journalArticle

Beijing
82 Citations (Scopus)
Angiotensin Receptor Antagonists
Valsartan
Chronic Renal Insufficiency
Proteinuria
Angiotensin-Converting Enzyme Inhibitors
24 Citations (Scopus)

Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

Carson, P., Tam, S. W., Ghali, J. K., Archambault, W. T., Taylor, A., Cohn, J. N., Braman, V. M., Worcel, M. & Anand, I., Dec 1 2009, In : Journal of Cardiac Failure. 15, 10, p. 835-842 8 p.

Research output: Contribution to journalArticle

African Americans
Heart Failure
Quality of Life
Mortality
Placebos
1 Citation (Scopus)

The president's page: Target response or target dose

Cohn, J. N., Aug 1 2009, In : Cardiovascular Drugs and Therapy. 23, 4, 1 p.

Research output: Contribution to journalArticle

Drug Dose Response Relationship
Cardiovascular Agents
Cardiovascular Diseases
19 Citations (Scopus)

Unconventional End Points in Cardiovascular Clinical Trials: Should We Be Moving Away From Morbidity and Mortality?

Cohn, J. N., Cleland, J. G. F., Lubsen, J., Borer, J. S., Steg, P. G., Perelman, M. & Zannad, F., Apr 1 2009, In : Journal of Cardiac Failure. 15, 3, p. 199-205 7 p.

Research output: Contribution to journalArticle

Clinical Trials
Morbidity
Mortality
Cardiology
Quality of Life
2008
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Ramipril
Disease Progression
Atherosclerosis
24 Citations (Scopus)

Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.

Anand, I., Rector, T. S., Kuskowski, M. A., Thomas, S., Holwerda, N. J. & Cohn, J. N., Jan 1 2008, In : Circulation. Heart failure. 1, 1, p. 34-42 9 p.

Research output: Contribution to journalArticle

Valsartan
Heart Failure
Blood Pressure
11 Citations (Scopus)

Exploring the Potential Synergistic Action of Spironolactone on Nitric Oxide-Enhancing Therapy: Insights From the African-American Heart Failure Trial

Ghali, J. K., Tam, S. W., Sabolinski, M. L., Taylor, A. L., Lindenfeld, J., Cohn, J. N. & Worcel, M., Nov 1 2008, In : Journal of Cardiac Failure. 14, 9, p. 718-723 6 p.

Research output: Contribution to journalArticle

Spironolactone
African Americans
Action Potentials
Nitric Oxide
Heart Failure
217 Citations (Scopus)

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

Masson, S., Latini, R., Anand, I. S., Barlera, S., Angelici, L., Vago, T., Tognoni, G. & Cohn, J. N., Sep 16 2008, In : Journal of the American College of Cardiology. 52, 12, p. 997-1003 7 p.

Research output: Contribution to journalArticle

Valsartan
Brain Natriuretic Peptide
Heart Failure
Confidence Intervals
Random Allocation
2007
78 Citations (Scopus)

Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction. A Pooled Analysis of 5 Randomized Control Trials

Frazier, C. G., Alexander, K. P., Newby, L. K., Anderson, S., Iverson, E., Packer, M., Cohn, J. N., Goldstein, S. & Douglas, P. S., Apr 3 2007, In : Journal of the American College of Cardiology. 49, 13, p. 1450-1458 9 p.

Research output: Contribution to journalArticle

Systolic Heart Failure
Confidence Intervals
Heart Failure
Survival
Kaplan-Meier Estimate
39 Citations (Scopus)
Valsartan
Blood Vessels
Blood Pressure
Cardiovascular Diseases
Elasticity
56 Citations (Scopus)

Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial

Cicoira, M., Maggioni, A. P., Latini, R., Barlera, S., Carretta, E., Janosi, A., Soler Soler, J., Anand, I. & Cohn, J. N., Apr 1 2007, In : European Journal of Heart Failure. 9, 4, p. 397-402 6 p.

Research output: Contribution to journalArticle

Valsartan
Body Mass Index
Heart Failure
Thinness
Mortality
60 Citations (Scopus)

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

Staszewsky, L., Wong, M., Masson, S., Barlera, S., Carretta, E., Maggioni, A. P., Anand, I. S., Cohn, J. N., Tognoni, G. & Latini, R., Dec 1 2007, In : Journal of Cardiac Failure. 13, 10, p. 797-804 8 p.

Research output: Contribution to journalArticle

Chronic Obstructive Pulmonary Disease
Heart Failure
Mortality
Valsartan
Confidence Intervals
64 Citations (Scopus)

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: Consistency across subgroups in the African-American Heart Failure Trial

Taylor, A. L., Ziesche, S., Yancy, C. W., Carson, P., Ferdinand, K., Taylor, M., Adams, K., Olukotun, A. Y., Ofili, E., Tam, S. W., Sabolinski, M. L., Worcel, M. & Cohn, J. N., Apr 1 2007, In : Circulation. 115, 13, p. 1747-1753 7 p.

Research output: Contribution to journalArticle

African Americans
Disease-Free Survival
Hospitalization
Heart Failure
Mortality
12 Citations (Scopus)

Effects of ACE inhibitors or β-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American heart failure trial

Ghali, J. K., Tam, S. W., Ferdinand, K. C., Lindenfeld, J. A., Sabolinski, M. L., Taylor, A. L., Worcel, M., Curry, C. L. & Cohn, J. N., Jan 1 2007, In : American Journal of Cardiovascular Drugs. 7, 5, p. 373-380 8 p.

Research output: Contribution to journalArticle

Angiotensin-Converting Enzyme Inhibitors
African Americans
Heart Failure
Angiotensin Receptor Antagonists
Placebos
54 Citations (Scopus)

Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial

Anand, I., Tam, S. W., Rector, T. S., Taylor, A. L., Sabolinski, M. L., Archambault, W. T., Adams, K. F., Olukotun, A. Y., Worcel, M. & Cohn, J. N., Jan 2 2007, In : Journal of the American College of Cardiology. 49, 1, p. 32-39 8 p.

Research output: Contribution to journalArticle

African Americans
Heart Failure
Blood Pressure
isosorbide-hydralazine combination
Hypotension

In Memorium. Louis Tobian

Cohn, J. N., Jan 1 2007, In : Journal of the American Society of Hypertension. 1, 1, p. 3-4 2 p.

Research output: Contribution to journalArticle

15 Citations (Scopus)

Is it the blood pressure or the blood vessel?

Cohn, J. N., Jan 1 2007, In : Journal of the American Society of Hypertension. 1, 1, p. 5-16 12 p.

Research output: Contribution to journalArticle

Blood Vessels
Blood Pressure
Pressure
Microcirculation
Hypertension